Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001577014-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 30, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
504,695
Total Value
$10,712,549.82
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 26, 2026 | Sale | 162,954 | $21.28 | $3,467,661.12 | 4,579,456 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 26, 2026 | Sale | 81,903 | $21.28 | $1,742,895.84 | 1,396,475 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 26, 2026 | Sale | 64,411 | $21.28 | $1,370,666.08 | 1,016,633 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 102,969 | $21.14 | $2,176,764.66 | 4,476,487 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 51,756 | $21.14 | $1,094,121.84 | 1,344,719 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 40,702 | $21.14 | $860,440.28 | 975,931 | Indirect | See footnote | View Details |